144 related articles for article (PubMed ID: 25668278)
21. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems.
Ta V; Chin WK; White AA
Dermatitis; 2014; 25(5):279. PubMed ID: 25207692
[No Abstract] [Full Text] [Related]
22. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
Seftel AD
J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797
[No Abstract] [Full Text] [Related]
23. [Androgen replacement therapy and prostate cancer].
Beuzeboc P; Richaud P
Prog Urol; 2003 Nov; 13(5 Suppl 2):1276-7. PubMed ID: 15816405
[No Abstract] [Full Text] [Related]
24. Monitoring androgen replacement therapy: testosterone and prostate safety.
Morales A
J Endocrinol Invest; 2005; 28(3 Suppl):122-7. PubMed ID: 16042371
[TBL] [Abstract][Full Text] [Related]
25. Testosterone replacement in elderly men.
Baum NH; Crespi CA
Geriatrics; 2007 Sep; 62(9):15-8. PubMed ID: 17824721
[TBL] [Abstract][Full Text] [Related]
26. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
Hájek J; Hanselová M; Vrubel F
Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
[No Abstract] [Full Text] [Related]
27. Menopause retrospective.
Johns Hopkins Med Lett Health After 50; 1999 Sep; 11(7):7. PubMed ID: 10472206
[No Abstract] [Full Text] [Related]
28. Summary for patients. Effect of testosterone on response to sildenafil in men with erectile dysfunction.
Ann Intern Med; 2012 Nov; 157(10):I-18. PubMed ID: 23165675
[No Abstract] [Full Text] [Related]
29. On lust and rage - prostate cancer, vasectomy and virility in the aging male.
Hodgson D
Aging Male; 2009 Mar; 12(1):1-4. PubMed ID: 19326291
[No Abstract] [Full Text] [Related]
30. Hormonal management of the female-to-male transgender patient.
Steinle K
J Midwifery Womens Health; 2011; 56(3):293-302. PubMed ID: 21535376
[TBL] [Abstract][Full Text] [Related]
31. Hormone therapy: a dangerous elixir?
Pearson H
Nature; 2004 Sep; 431(7008):500-1. PubMed ID: 15457228
[No Abstract] [Full Text] [Related]
32. Safety of testosterone replacement therapy.
Med Lett Drugs Ther; 2016 Mar; 58(1490):33-4. PubMed ID: 26963153
[No Abstract] [Full Text] [Related]
33. Testosterone administration in older men.
Matsumoto AM
Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
[TBL] [Abstract][Full Text] [Related]
34. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
[TBL] [Abstract][Full Text] [Related]
35. Testosterone replacement therapy in prostate cancer patients: is it safe?
Umbas R; Sugiono M
Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
[TBL] [Abstract][Full Text] [Related]
36. Hormone therapy in cancer.
Kennedy BJ
Geriatrics; 1970 Oct; 25(10):106-12. PubMed ID: 4096937
[No Abstract] [Full Text] [Related]
37. [Prostate and hormone replacement therapy].
Pompeo AC; Damião R; Campos RM; Lopes EJ
Int Braz J Urol; 2006; 32 Suppl 1():35-8. PubMed ID: 23631040
[No Abstract] [Full Text] [Related]
38. Studies on extragonadal androgen: hormonal changes of the prostatic cancer patients on antiandrogenic therapy after orchiectomy.
Fukuda Y
Kobe J Med Sci; 1968 Mar; 14(1):1-23. PubMed ID: 5674440
[No Abstract] [Full Text] [Related]
39. Testosterone-induced activation of fibrinolysis in carcinoma of the prostate.
Rosswick RP
Br J Urol; 1967 Apr; 39(2):143-6. PubMed ID: 6025389
[No Abstract] [Full Text] [Related]
40. [Cancer of the prostate treated with 1 mg per day of diethylstilbestrol. Value of the determination of salivary free testosterone].
Steg A; Laudat MH; Zerbib M; Guiban D
Presse Med; 1988 Feb; 17(6):282. PubMed ID: 2964628
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
